KU Center for Neuroprotection in Parkinson's Disease

KU 帕金森病神经保护中心

• 批准号: 7559491
• 负责人: RAJESH PAHWA
• 金额: $ 9.02万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-01-20 至 2012-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7559491
• 关键词: Certification; Cities; Clinical Practice Guideline; Clinical Trials; Conduct Clinical Trials; Confidentiality; Data; Data Collection; Disease; Documentation; Double-Blind Method; Ensure; Environment; Kansas; Monitoring Clinical Trials; National Institute of Neurological Disorders and Stroke; Parkinson Disease; Participant; Patient Recruitments; Patients; Performance; Pharmaceutical Preparations; Pilot Projects; Process; Protocols documentation; Randomized Clinical Trials; Recruitment Activity; Research; Research Personnel; Safety; Specimen; Support Groups; Training; United States National Institutes of Health; Universities; Work; experience; neuroprotection

DESCRIPTION (provided by applicant): The University of Kansas has all of the necessary components to become a Parkinson's Disease Neuroprotection Clinical Trial Center. The University of Kansas is an established Clinical Trials Center with the necessary space to efficiently conduct clinical trials, prepare and process lab specimens and securely and confidentially maintain study medication and documentation. An experienced clinical trial team is currently in place to assure that the studies are conducted in a manner that allows for accurate, efficient and timely collection of data and provides a safe and pleasant environment for the patients. The Clinical Trial Staff have all received training and certification to conduct clinical trials from the University of Kansas Research Compliance Office and have been trained and currently follow Good Clinical Practice Guidelines to assure the safety and protection of study participants. The Principle Investigator, Dr. Rajesh Pahwa, has extensive experience in developing, conducting and monitoring clinical trials and an excellent track record in the recruitment of patients. The Center currently works closely with the Parkinson Association of Greater Kansas City, and all of its support groups to facilitate patient recruitment. The University of Kansas Parkinson's Disease Center is willing and dedicated to adhere to a common protocol and to cooperate with other centers and NINDS in the conduct of both pilot studies and the main efficacy study.

描述（由申请人提供）：堪萨斯大学拥有成为帕金森氏病神经保护临床试验中心的所有必要组成部分。堪萨斯大学是一个既定的临床试验中心，具有有效进行临床试验，准备和处理实验室标本的必要空间，并安全，秘密地维护研究药物和文档。目前，有一个经验丰富的临床试验团队确保以准确，高效且及时收集数据的方式进行研究，并为患者提供安全愉快的环境。临床试验人员均已获得培训和认证，以从堪萨斯大学研究合规办公室进行临床试验，并接受了培训，目前遵循良好的临床实践指南，以确保对研究参与者的安全和保护。主要研究者Rajesh Pahwa博士在开发，进行和监测临床试验方面拥有丰富的经验，并且在招募患者方面具有出色的往绩。该中心目前与大堪萨斯城的帕金森协会及其所有支持小组密切合作，以促进患者招募。堪萨斯大学帕金森氏病中心愿意并致力于遵守共同的方案，并与其他中心和Ninds合作，同时进行试点研究和主要疗效研究。